SCHEMBL21155529

SCHEMBL21155529

Cc1cccc2cnc(Nc3ccc(N4CCN(C(=O)OC(C)(C)C)CC4)cc3)nc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 5/20 0.68
▸ CCND3 P30281 2/20 0.68
▸ CCNK O75909 1/20 0.68
▸ CCNA2 P20248 1/20 0.68
▸ CDK9 P50750 1/20 0.68
▸ CDK6 Q00534 1/20 0.68
▸ CDK4 P11802 5/20 0.58
▸ CCND1 P24385 5/20 0.58
▸ CCND2 P30279 1/20 0.58
▸ JAK2 O60674 4/20 0.56
▸ JAK3 P52333 2/20 0.56
▸ PTK2 Q05397 1/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ SYK P43405 2/20 0.53
▸ CCNE1 P24864 4/20 0.51
▸ EGFR P00533 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29847699 0.87 JAK2 (0.62) CDK2CCND3CCNKCCNA2CDK9
SCHEMBL16514118 0.87 JAK2 (0.62) CDK2CCND3CCNKCCNA2CDK9
SCHEMBL16513933 0.86 CDK2 (0.58) CDK2CCND3CCNKCCNA2CDK9
SCHEMBL16513502 0.86 CCND3 (0.65) CDK2CCND3CCNKCCNA2CDK9
SCHEMBL16513586 0.84 EGFR (0.59) CDK2CCND3CCNKCCNA2CDK9
SCHEMBL29847649 0.84 EGFR (0.59) CDK2CCND3CCNKCCNA2CDK9
SCHEMBL16513819 0.84 EGFR (0.59) CDK2CCND3CCNKCCNA2CDK9
SCHEMBL29848021 0.84 EGFR (0.59) CDK2CCND3CCNKCCNA2CDK9
SCHEMBL16513575 0.83 CCND3 (0.57) CDK2CCND3CCNKCCNA2CDK9
SCHEMBL28459543 0.81 CCNA2 (1.00) CDK2CCND3CCNKCCNA2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3508204-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Neupharma, Inc. (US) 2019-07-10 — — EP disclosed
Send feedback